Citadel Advisors - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$8,071,208
-19.8%
160,717
+1.0%
0.00%0.0%
Q2 2023$10,060,113
-31.7%
159,179
-51.4%
0.00%
-33.3%
Q1 2023$14,732,201
+18.6%
327,455
+15.5%
0.00%
+50.0%
Q4 2022$12,425,480
-51.9%
283,622
-27.6%
0.00%
-66.7%
Q3 2022$25,821,000
+105.7%
391,887
+57.7%
0.01%
+100.0%
Q2 2022$12,554,000
-56.8%
248,559
-45.4%
0.00%
-50.0%
Q1 2022$29,081,000
+158.0%
455,239
+332.7%
0.01%
+200.0%
Q4 2021$11,270,000
+823.8%
105,214
+786.2%
0.00%
Q3 2021$1,220,000
-13.3%
11,873
-25.8%
0.00%
Q2 2021$1,407,000
-20.5%
15,993
-12.1%
0.00%
Q1 2021$1,770,000
-68.5%
18,200
-63.7%
0.00%
-100.0%
Q4 2020$5,619,000
-40.9%
50,103
-51.1%
0.00%
-33.3%
Q3 2020$9,502,000
-73.9%
102,491
-78.0%
0.00%
-76.9%
Q2 2020$36,404,000
+25.2%
466,710
-6.1%
0.01%0.0%
Q1 2020$29,080,000
+171.8%
497,267
+272.3%
0.01%
+225.0%
Q4 2019$10,699,000
-38.9%
133,559
-44.0%
0.00%
-55.6%
Q3 2019$17,519,000
+102.4%
238,443
+159.8%
0.01%
+125.0%
Q2 2019$8,656,000
-5.2%
91,764
-19.6%
0.00%0.0%
Q1 2019$9,132,000
+226.5%
114,090
+119.9%
0.00%
+300.0%
Q4 2018$2,797,000
-86.6%
51,889
-80.6%
0.00%
-90.0%
Q3 2018$20,898,000
+236.6%
267,709
+173.7%
0.01%
+233.3%
Q2 2018$6,208,000
+24.2%
97,795
+79.4%
0.00%0.0%
Q1 2018$4,999,000
-24.9%
54,516
-38.2%
0.00%
-25.0%
Q4 2017$6,656,000
+114.2%
88,258
+97.9%
0.00%
+33.3%
Q3 2017$3,107,000
-82.6%
44,600
-87.3%
0.00%
-80.0%
Q2 2017$17,809,000
+134.7%
351,482
+85.2%
0.02%
+150.0%
Q1 2017$7,589,000
+262.1%
189,774
+154.0%
0.01%
+200.0%
Q4 2016$2,096,000
+278.3%
74,711
+300.6%
0.00%
+100.0%
Q3 2016$554,000
-84.7%
18,650
-86.4%
0.00%
-75.0%
Q4 2015$3,617,000
-69.0%
137,303
-74.9%
0.00%
-63.6%
Q3 2015$11,673,000
-35.5%
546,991
-20.0%
0.01%
-31.2%
Q2 2015$18,108,000683,5840.02%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 645,539$69,144,0007.84%
DAFNA Capital Management LLC 206,911$22,162,0005.57%
Eagle Health Investments LP 192,639$20,634,0005.03%
Casdin Capital, LLC 1,550,000$166,021,0004.68%
CADIAN CAPITAL MANAGEMENT, LP 450,657$48,270,0002.65%
Avidity Partners Management LP 995,000$106,574,0002.26%
Integral Health Asset Management, LLC 75,000$8,033,0002.22%
Rock Springs Capital Management LP 859,755$92,088,0002.13%
Boxer Capital, LLC 507,374$54,345,0002.11%
EFG Asset Management (North America) Corp. 112,715$12,082,0001.58%
View complete list of BLUEPRINT MEDICINES CORP shareholders